Drugplain

Methylphenidate Hydrochloride Extended-Release 20 mg/1

methylphenidate hydrochloride · CAPSULE, EXTENDED RELEASE · SpecGx LLC

No Recall HistoryCurrently in Shortage
Plain English

Methylphenidate Hydrochloride Extended-Release is a capsule, extended release containing methylphenidate hydrochloride at 20 mg/1, taken oral. Manufactured by SpecGx LLC.

Key Facts

Brand Name
Methylphenidate Hydrochloride Extended-Release
Generic Name
methylphenidate hydrochloride
NDC Code (Product)
0406-1820
Manufacturer
SpecGx LLC
Strength
20 mg/1
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
ANDA203583
Marketing Start
09/29/2015

Recall History

No Recall History

Frequently Asked Questions

What is Methylphenidate Hydrochloride Extended-Release used for?

Methylphenidate Hydrochloride Extended-Release contains methylphenidate hydrochloride. It is a capsule, extended release taken oral. Consult your doctor for specific uses.

Is Methylphenidate Hydrochloride Extended-Release a controlled substance?

Yes, Methylphenidate Hydrochloride Extended-Release is classified as CII under the DEA Controlled Substances Act.

What is the generic name for Methylphenidate Hydrochloride Extended-Release?

The generic name for Methylphenidate Hydrochloride Extended-Release is methylphenidate hydrochloride. There are 12 other brand versions of methylphenidate hydrochloride.

What is the NDC code for Methylphenidate Hydrochloride Extended-Release 20 mg/1?

The NDC (National Drug Code) for Methylphenidate Hydrochloride Extended-Release 20 mg/1 is 0406-1820, listed by SpecGx LLC.